BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23499591)

  • 1. Hepatitis C virus vaccines--progress and perspectives.
    Fauvelle C; Lepiller Q; Felmlee DJ; Fofana I; Habersetzer F; Stoll-Keller F; Baumert TF; Fafi-Kremer S
    Microb Pathog; 2013 May; 58():66-72. PubMed ID: 23499591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
    Beaumont E; Roingeard P
    Hum Vaccin Immunother; 2013 May; 9(5):1112-8. PubMed ID: 23406827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New approaches to immune against hepatitis C virus].
    Sela B
    Harefuah; 2002 Dec; 141(12):1076-80, 1089. PubMed ID: 12534208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C vaccine. Need of the hour.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(7):1927-9. PubMed ID: 25424801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
    Baumert TF; Fauvelle C; Chen DY; Lauer GM
    J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
    Roohvand F; Kossari N
    Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
    Torresi J; Johnson D; Wedemeyer H
    J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities.
    Roohvand F; Kossari N
    Expert Opin Ther Pat; 2012 Apr; 22(4):391-415. PubMed ID: 22455502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Virology of hepatitis C virus].
    Hofmann H
    Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
    Alvarez-Lajonchere L; Dueñas-Carrera S
    Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro models for analysis of the hepatitis C virus life cycle.
    Aly HH; Shimotohno K; Hijikata M; Seya T
    Microbiol Immunol; 2012 Jan; 56(1):1-9. PubMed ID: 22145950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C virus vaccine].
    Wakita T
    Nihon Rinsho; 2008 Oct; 66(10):1961-4. PubMed ID: 18939497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.
    Houghton M
    Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of improved mouse models for the study of hepatitis C virus.
    Douglas DN; Kneteman NM
    Eur J Pharmacol; 2015 Jul; 759():313-25. PubMed ID: 25814250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic options for hepatitis C.
    Waters L; Nelson M
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.